Document Detail


Transcatheter closure of atrial septal defects in children & adults using the Amplatzer Septal Occluder.
MedLine Citation:
PMID:  12053325     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We are reporting the worldwide experience in closing atrial septal defects (ASDs) in children and adults using the Amplatzer Septal Occluder (ASO) as of July 2000. The outcome measures were safety and efficacy with special emphasis on: (1) immediate success of the ASD closure as measured by transesophageal echocardiography (TEE), (2) short- and medium-term follow-up at 24 hours and 1 and 3 months and long-term follow-up at 1, 2, and 3 years as assessed by transthoracic echocardiography (TTE); and (3) the incidence of complications. In all, 3580 procedures were performed in 3535 patients. In 75 patients, the device was not implanted for variety of reasons; 3460 patients received a single ASO device and 45 received two devices for multiple ASDs. The median age of the patients was 12.1 year, (range, 10 days-88 years, the median weight was 41.0 kg (range, 2.4-137 kg) and the median Qp/Qs ratio was 2 (range, 0.3-10). The median size of ASD by TEE was 14 mm (range, 1-38 mm) and the median stretched diameter was 18 mm (range, 4-44 mm). The median size of device implanted was 18 mm (range, 4-40 mm). The median fluoroscopy time was 17.1 minutes (range, 0.0-194.0 minutes). The immediate success rate including those patients with complete closure, trivial residual shunt, or with small residual shunt was 97.4%. This increased to 99.2% and 100% at 3 months and 3 years, respectively. Minor complications were encountered in 2.8% of procedures, while serious complications occurred in less than 0.3% of the cases. There were no device related deaths. We conclude that the ASO is a safe and effective device for catheter closure of small to large ASDs up to a stretched diameter of 40 mm in children and adults with very high short-, medium, and long-term success rates.
Authors:
A Omeish; Z M Hijazi
Related Documents :
10535825 - Transcatheter closure as standard treatment for most interatrial defects: experience in...
1934405 - Doppler color flow mapping assessment of residual shunt after closure of large ventricu...
19735475 - Figulla asd occluder versus amplatzer septal occluder: a comparative study on validatio...
20419985 - Is early correction of congenital ventricular septal defect a better option in a develo...
6224455 - Clinical utilization of injectable collagen.
22231545 - Maximum voluntary ventilation as a sensitive measure to monitor the ventilatory functio...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of interventional cardiology     Volume:  14     ISSN:  0896-4327     ISO Abbreviation:  J Interv Cardiol     Publication Date:  2001 Feb 
Date Detail:
Created Date:  2002-06-10     Completed Date:  2002-06-28     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8907826     Medline TA:  J Interv Cardiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  37-44     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Section of Pediatric Cardiology, University of Chicago Children's Hospital, Pritzker School of Medicine, Chicago, Illinois, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Aged, 80 and over
Child
Child, Preschool
Embolization, Therapeutic / instrumentation*
Heart Catheterization
Heart Septal Defects, Atrial / therapy*
Humans
Infant
Infant, Newborn
Middle Aged
Prostheses and Implants

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Early experience with the Amplatzer ductal occluder for closure of the persistently patent ductus ar...
Next Document:  The use of Amplatzer devices to occlude vascular fistulae.